Creator Post Archive
Asymmetric Investing by Travis Hoium
Browse the full post archive, then jump into the source post to inspect linked mentions and linked signals.
May 21, 2026
Hot Startups in 2026: How to Buy SpaceX, Anthropic, Figure & More
The creator discusses how startups are staying private longer, limiting early access for retail investors. He explores two main ways to gain exposure: through publicly traded companies that invest in startups and through private market platforms like Jacy that tokenize ownership. Several public companies like Alphabet, Amazon, Microsoft, and Nvidia are highlighted for their venture investments in private companies such as SpaceX, Anthropic, and OpenAI.
May 21, 2026
Oscar Health: A Pirate Ship Among Spanish Galleons
The creator discusses Oscar Health, a health insurance company operating in the ACA market, highlighting its unique "pirate ship" strategy compared to larger competitors. The company focuses on personalized, lifestyle-based plans and aims to disrupt the industry by putting the individual consumer first, offering greater choice and potentially lower costs. The discussion touches on the high cost of healthcare in the US and Oscar Health's approach to addressing this through tailored products and a focus on lifetime member value.
May 19, 2026
Zeta Global's Massive AI Growth Plans Just Got a Lot Bigger
Zeta Global (ZETA) has announced two significant updates: a partnership with OpenAI to enhance its advertising platform and the introduction of Athena, an AI co-pilot designed to make its marketing operating system more accessible and outcome-driven for enterprise clients. The creator, who owns ZETA stock, believes these developments position the company for substantial future growth by increasing platform utilization and value extraction.
May 19, 2026
Why Hims & Hers Stock Just Dropped (And What Happens Next) | $HIMS
Hims & Hers is raising $350 million in convertible debt to fund acquisitions and investments, which has caused the stock to drop. The debt has a 0% interest rate and is convertible into stock at $29.53 per share, with a capped call transaction limiting dilution to $50.15 per share. This move indicates an aggressive expansion strategy by management.
Showing 26-29 of 29 posts · Page 2 of 2